EUVIMEDEUVIMED entdecken
Crossref

Erythrocyte phosphatidylserine externalization shows greater discriminatory performance than red cell distribution width for early recurrence or progression in hepatocellular carcinoma

Maoqing Tan, Wei Dai, Danni Cai, Yilin Shi, Junsheng Lin, Jun Huang, Jingru Liu, Xinai Liao, Dongliang Li, Huifang Huang

Journal of Gastroenterology · 29.10.2026

DOI: 10.1007/s00535-026-02529-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 29.10.2026. Verfasst von Maoqing Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. Die Arbeit nennt 36 Literaturangaben. Gefördert von: the Fujian Provincial Government-Funded Project for the Construction of a High-Level Laboratory in China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Red cell distribution width (RDW) is associated with adverse outcomes in hepatocellular carcinoma (HCC), but whether this association reflects an HCC-associated erythrocyte injury phenotype remains unclear. We investigated whether phosphatidylserine (PS) externalization identifies an HCC-associated erythrocyte injury phenotype and is associated with tumor burden and early recurrence or progression.

Methods

This prospective two-center clinical study included 97 patients with newly diagnosed HCC, 30 healthy donors, 13 patients with chronic hepatitis B, and 17 patients with HBV-related cirrhosis as disease controls. Erythrocyte injury phenotypes were characterized by flow cytometry, metabolomics, and proteomics. Findings were examined in orthotopic HCC mouse models and erythrocyte-HCC co-culture systems.

Results

PS externalization was elevated in patients with HCC and correlated with tumor diameter, multiplicity, metastasis, and Barcelona Clinic Liver Cancer stage. HCC also showed higher PS levels than chronic hepatitis B and HBV-related cirrhosis controls. Higher PS externalization remained independently associated with early recurrence or progression within 6 months after adjustment for maximum tumor diameter, tumor number, and lymph-node and/or distant metastasis (OR = 1.382; 95% CI 1.112–1.717; P = 0.004). PS showed greater discriminatory performance than RDW-CV (AUC 0.804 versus 0.642; paired DeLong P = 0.003); bootstrap internal validation of the primary multivariable model yielded an optimism-corrected AUC of 0.780. Spatial analyses revealed progressive erythrocyte injury from peripheral blood to adjacent non-tumor tissue to primary tumor. In orthotopic HCC-bearing mice, PS externalization preceded RDW elevation. Direct co-culture with HCC cells induced glutathione depletion and oxidative membrane injury, which were attenuated by N-acetylcysteine and reproduced by glutathione synthesis inhibition. Multi-omics analyses revealed alterations in pentose phosphate pathway (PPP)–NADPH/glutathione metabolism and membrane-skeletal proteins.

Conclusions

PS externalization identifies an HCC-associated erythrocyte injury phenotype and is a candidate marker for 6-month recurrence or progression. Experimental findings support a functional contribution of glutathione depletion to membrane injury, accompanied by PPP–NADPH-related metabolic and membrane-skeletal alterations.

Schlagwörter

Stichwörter der Autor:innen

ErythrocytesGlutathioneHepatocellular carcinomaOxidative stressPhosphatidylserine

Autor:innen und Institutionen

  • Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
  • Department of Hepatobiliary Disease, 900th Hospital of PLA Joint Logistics Support Force, Fuzong Clinical Medical College of Fujian Medical University, 156 Xi Er Huan Bei Road, Fuzhou, 350025, Fujian, China.
  • School of Medical Technology and Engineering, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
  • Department of Clinical Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
  • Department of Hepatobiliary Disease, 900th Hospital of PLA Joint Logistics Support Force, Fuzong Clinical Medical College of Fujian Medical University, 156 Xi Er Huan Bei Road, Fuzhou, 350025, Fujian, China. dongliangli…
  • Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. huanghuif@fjmu.edu.cn.

Förderung

  • the Fujian Provincial Government-Funded Project for the Construction of a High-Level Laboratory in China

Zitieren

APA

Tan, M., Dai, W., Cai, D., Shi, Y., Lin, J., Huang, J., Liu, J., Liao, X., Li, D., & Huang, H. (2026). Erythrocyte phosphatidylserine externalization shows greater discriminatory performance than red cell distribution width for early recurrence or progression in hepatocellular carcinoma. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02529-8

Vancouver

Tan M, Dai W, Cai D, Shi Y, Lin J, Huang J, et al. Erythrocyte phosphatidylserine externalization shows greater discriminatory performance than red cell distribution width for early recurrence or progression in hepatocellular carcinoma. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02529-8

BibTeX
@article{Tan2026,
  author = {Tan, Maoqing and Dai, Wei and Cai, Danni and Shi, Yilin and Lin, Junsheng and Huang, Jun and Liu, Jingru and Liao, Xinai and Li, Dongliang and Huang, Huifang},
  title = {Erythrocyte phosphatidylserine externalization shows greater discriminatory performance than red cell distribution width for early recurrence or progression in hepatocellular carcinoma},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02529-8}
}
Kostenlos starten →